The record, counted by model type
The published record on this compound is filed as a count, not a summary. Each row below sits at one model type, gives one representative record, and states what that model type cannot settle. The highest model reporting an outcome is human observational. No human study in the set gave this compound to anybody.
[ four columns, scroll the panel sideways for the full row ]
| Model type | Records at this model type | One representative record | What this model type cannot settle |
|---|---|---|---|
| review | 8 | PubMed 36761202 | A review reports what other records reported. It runs no experiment of its own and adds no outcome to the set. |
| animal | 5 | PubMed 25738459 | An animal model reports what happened in that species in that model. It settles nothing about a person. |
| in vitro | 2 | PubMed 29983246 | Work in cells reports what happened in cells. It settles nothing about an animal or a person. |
| human observational | 2 | PubMed 31214116 | Measuring what already circulates in people is not the same as giving them anything. An association settles no cause and no outcome. |
registered trial records: 9
completed administration trials reporting an outcome: 0
The table carries no direction column, and that is deliberate. A direction column read fast becomes a claim about a person, and this register makes none. Eight reviews, five animal records, two in vitro records and two human observational records total seventeen with a model type, beside nine registered trial records and no completed administration trial reporting an outcome.
The two human observational records are a cross-sectional serum study of 225 subjects, cited to PubMed 31214116, and a physiology study in PCOS and healthy subjects measuring what was already circulating, cited to PubMed 31066084. Neither gave this compound to anybody, and neither direction is printed here.
The one registered administration study
One registered administration study sits in the set, NCT07505745, phase 2, status recruiting, registered under the title MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity. A registration reports no outcome, and a recruiting study has produced none.
No other registered record is filed here. The remainder measure this compound in people rather than administering it, and mixing the two classes would blur the distinction this page draws. Nine registered trial records exist in the set; one administers this compound, and it reports nothing yet.
What the literature leaves unsettled
The literature discusses that no effective method of applying this compound in the clinic has been developed, cited to PubMed 36761202. It is carried as something the literature discusses, never as this register's own conclusion.
A 2026 sports medicine review records that rigorous human safety data are lacking for unapproved peptides and that potential for serious harm exists, cited to PubMed 41966639. It is reported as an absence of data, never converted into a warning addressed to a person.
The literature also discusses reports of a contrary direction in senescent cells, cited to PubMed 30058454. A record set that holds a contrary report beside the rest is a record set that is not settled, which is the reading this page files and the whole of it.
A count is a reading of the records, not a claim beyond them.
Scope and research use
This site reads published pages. It reports which page carries a name, which page leaves it out, and on what date each page was open. It describes no compound, and it says nothing whatever regarding the effect of any material upon anybody. Whatever a supplier files under research grade is entered here as research material and as nothing else. No line published here is medical advice, and nobody reading a page of it is told to do anything.
Questions filed about the publisher
The surfaces this register reads belong to one publisher
What is Peptara Labs, on its own pages?
Peptara Labs states on its own pages that it supplies research-grade compounds and educational information and is not a medical provider. Its certificate index lists sixteen research-grade products. This register reads that publisher's pages for one name and files what each carries, and it publishes no verdict about the company.
Who does Peptara Labs name as its testing laboratory?
Peptara Labs names Titreon Analytical, described on the live page as a third-party laboratory whose quality system is aligned to ISO/IEC 17025:2017, not itself accredited. The qualifier travels with the name here, whole and never shortened.
Does Peptara Labs publish certificates of analysis?
Yes. Fourteen of the sixteen listed products carry a published certificate and two carry none. Whether any single file was opened here is a separate question, filed on the index entry for this compound. This record page itself links only public research records.